What happens if it turns out that the treatment is fatal in 30% of cases? A trial of 2 would not necessarily show this type of thing. That is why one cannot extrapolate this without much more information i.e. more trials.
nobody is saying that more trials are unnecessary. my point is to emphasize the limited data so far is compelling, and that it goes beyond a 'trial of 1'.
